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Abstract
Transport across the cell membrane is crucial in drug delivery. However, the
process is complicated because nucleoside derivatives that are commonly used as
anti-viral drugs are transported through two di®erent types of speci¯c transporter:
concentrative transporters and equilibrative transporters. Cross-disciplinary ap-
proaches involving both biological experiments and theoretical considerations are
therefore necessary to study the transport of nucleoside analogues such as ribavirin.
Here we constructed an experimental model system using the Xenopus laevis oocyte
that expressed examples of both types of transporter: human concentrative nucle-
oside transporter 3 and human equilibrative transporter 1. We also performed a
kinetic study. Experimental results showed that the transport of ribavirin could be
reduced by inhibiting one of the two types of transporter, which seems to be coun-
terintuitive. We therefore designed a simple mathematical model of the dynamics
of ribavirin uptake and analyzed the model behaviors using a numerical simula-
tion. The theoretical results reproduced the experimentally observed phenomena
and suggested a possible mechanism for the process. Based on this mechanism,
we predicted some potential methods for the e®ective uptake of ribavirin from a
dynamics point of view.
1 Introduction
Nucleoside analogues are commonly used as anti-cancer and anti-viral drugs. The adeno-
sine analogue 1-¯-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide (ribavirin) is one such
example. This broad-spectrum anti-viral drug has recently been used for the treatment
of patients infected with the hepatitis C virus[1, 2]. The delivery of a drug across the cell
membrane needs to be well understood in order to clarify the mechanism underlying its ef-
fects. Additionally, from a physiological point of view, the transport of nucleosides across
the cell membrane is important as, along with their analogues, they play crucial roles in
living systems and have various physiological regulatory functions in di®erent organs. For
instance, the adenosine nucleoside regulates coronary vasodilation, renal vasoconstriction,
neurotransmission, platelet aggregation, and lipolysis[3, 4].
The uptake of nucleoside analogues into the cell is mediated by two di®erent types
of speci¯c transporter: concentrative transporters and equilibrative transporters[5, 6].
Concentrative nucleoside transporters (CNTs) are symporters that simultaneously carry
a nucleoside molecule and sodium ions. As the concentration of sodium ions is much
lower inside the cell than outside, CNTs can function as active transporters according to
the sodium concentration gradient. So far, three subtypes of CNTs have been identi¯ed
in humans: hCNT1, which is pyrimidine nucleoside-selective; hCNT2, which is purine
nucleoside-selective; and hCNT3, which is broadly selective for both pyrimidine and purine
nucleosides[7, 8, 9, 10]. Generally, CNTs have a higher a±nity for nucleosides than that
of equilibrative nucleoside transporters (ENTs)[5]. ENTs are passive transporters, for
which the motive force of transport is the di®erence in nucleoside concentration across a
membrane[11, 12]. The uptake of nucleosides is a complex process due to the involvement
of these two di®erent types of transporter.
Our comprehension of nucleoside transport across cell membranes has been further
complicated by reports of seemingly counterintuitive phenomena [13]. This might be
because of the di®erent types of transporter involved[14], and the complex coupling of
the processes of metabolism and signal transduction of nucleosides [15]. To clarify the
e®ects of these factors on nucleoside transport, it could be useful to design and analyze a
simpli¯ed arti¯cially reconstructed experimental system.
Here, we shed light on the kinetics of combination of both types of transporter.
We constructed an experimental model cell system using the Xenopus laevis oocyte, in
which both types of transporter, hCNT and hENT, were coexpressed. It is important
to note that the expressed transporters were not rodent but human. Using this model
cell system, we performed a kinetic study of ribavirin uptake and tested the e®ects of the
speci¯c inhibition of each type of transporter.
Our results revealed that the uptake of ribavirin was facilitated by the inhibition
of an ENT, even though the ribavirin concentration was comparatively high outside of
the cell. This phenomenon involved both the complexity of the coupled dynamics of the
two transporters and spatial di®usion. We further investigated this e®ect by constructing
and numerically analyzing a simple mathematical model for the dynamics of ribavirin
transport.
The insights into the interactive e®ects of CNTs and ENTs revealed by our simpli¯ed
model system of the oocyte led us to propose some possible methods for the e®ective
uptake of ribavirin in intrinsic human cell systems. One such method was the organ-
selective delivery of ribavirin depending on di®erences in the CNT/ENT ratio, which
was based on the dynamic characteristics of the behaviors shown by the model. The
cross-disciplinary approach involving biological and mathematical sciences proved to be
a powerful tool in the current study.
2 Experimental study of kinetics of ribavirin trans-
port
2.1 Materials and methods
2.1.1 Materials
[3H]-ribavirin was purchased from Moravek Biochemicals (Brea, CA) and ribavirin was
purchased from ICN Biomedicals (Aurora, OH). Nitrobenzeylmercaptopurine ribonucle-
oside (NBMPR), which inhibits ENTs but not CNTs, was purchased from Sigma (St.
Louis, MO). All other compounds were of reagent grade.
2.1.2 Expression of recombinant hCNT3 and hENT1 in Xenopus oocytes
The molecular cloning of hCNT3 and hENT1 was as previously described[16]. hCNT3
and hENT1 complementary RNAs (cRNAs) were synthesized from a linearized plasmid
using mMESSAGE mMACHINE and a poly(a) tailing kit (Ambion, Austin, TX). Mature
oocytes from Xenopus laevis were isolated by treatment with 2 mg/ml collagenase (Wako,
Okasa, Japan), manually defolliculated, and maintained at 16oC in modi¯ed BarthÅ?fs
solution (88 mM NaCl, 1 mM KCl, 0.41 mM CaCl2, 0.3 mM Ca(NO3)2, 0.82 mM MgSO4,
2.4 mM NaHCO3, 15 mM Tris, and 0.05 mg/mL gentamicin; pH adjusted to 7.4 by HCl).
On the following day, the oocytes were microinjected with either 50 nL water containing
cRNA or 50 nL water alone. The injected oocytes were incubated in modi¯ed BarthÅ?fs
solution (which was changed daily) for either 3 days (radioisotope-transport studies) or
3-4 days (electrophysiological studies) at 16oC.
2.1.3 Radioisotope-transport studies
Uptake experiments were performed at room temperature[16]. The transport bu®er used
in this study was ND96 solution (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2,
and 5 mM HEPES; pH adjusted to 7.4 by Tris). Sodium-free bu®er was used in which
Na+ was replaced by N-methyl-D-glucamine (NMDG). As NBMPR has low solubility in
the bu®er, it was ¯rst dissolved in dimethyl sulfoxide (DMSO) and then further diluted in
the transport bu®er (0.1% v/v). DMSO alone was added to the bu®er without NBMPR
(control). The oocytes were incubated in 100 ¹L transport bu®er containing ribavirin. At
the end of the incubation, the oocytes were washed ¯ve times with ice-cold ND96 solution.
Then, the oocytes were dissolved in 10% sodium dodecyl sulfate (SDS) solution, and the
radioactivity was measured by a liquid scintillation counter. The uptake of ribavirin was
calculated by subtracting the rate of uptake by water-injected oocytes from the rate of
uptake by cRNA-injected oocytes.
2.1.4 Electrophysiological studies
The electrophysiological studies were performed using the two-microelectrode voltage
clamp (TEVC) technique[17, 18]. The microelectrode was prepared from glass capil-
laries (Hirschmann Laborgerate, Eberstadt, Germany) with the PC-10 Puller (Narishige,
Tokyo, Japan), which had a resistance of 1.0-1.5 M­ and was ¯lled with 3 M KCl. The
oocytes were penetrated with the microelectrodes and perfused with the same bu®er used
for radioisotope-transport studies at 20oC. The membrane potential of the oocytes was
generally held at -50 mV, and the substrate-induced membrane current was measured us-
ing the two-electrode voltage clamp ampli¯er CEZ-1250 (Nihon Kohden Industry, Tokyo,
Japan). For the current-voltage relationship study, the membrane potential was changed
from +50 mV to -150 mV (in 20 mV decrements) using a personal computer (PC) via the
analog-to-digital/digital-to-analog (AD/DA) converter PCI-360216 (Interface, Hiroshima,
Japan).
2.2 Ribavirin uptake by Xenopus oocytes coexpressing hCNT3
and hENT1
2.2.1 E®ect of Na+ and NBMPR on uptake of ribavirin
We examined the e®ects of transporter inhibition on the uptake rate of ribavirin, as shown
in Fig. 1a. The uptake was 0.02 pmol/oocyte/min when both types of transporter were
not inhibited ('NaCl' in Fig. 1a), whereas the inhibition of hENT ('Na+ and NBMPR')
increased the uptake by four times to 0.08 pmol/oocyte/min. This implied the presence
of an underlying interaction between the two types of transporter. By contrast, the
inhibition of hCNT ('NMDG Cl') decreased the uptake by half to 0.01 pmol/oocyte/min
compared to that with no inhibition. This ¯nding was understandable. When both types
of transporter were inhibited ('NMDG + NBMPR'), the uptake was negligible (less than
0.001 pmol/oocyte/min). Figure 1b shows the time courses of uptake under the di®erent
conditions. For all of the conditions involving inhibition, the uptake was proportional to
the time for the ¯rst 5 to 30 min. This linearity of uptake indicates that both types of
transporter work e®ectively in the oocyte.
2.2.2 Concentration-dependent uptake of ribavirin
To characterize the kinetics of the ribavirin uptake under the conditions involving inhi-
bition, we examined the concentration dependency. During the time course of uptake,
we found that the uptake of ribavirin increased linearly for at least 30 min (Fig. 1b).
However, after ribavirin has been transported into the oocyte, it is expected to be metab-
olized; this might signi¯cantly decrease the amount of non-metabolized ribavirin in the
oocyte, and a®ect the transport of ribavirin. Therefore, to avoid any e®ect of metabolism,
we shortened the incubation time as much as possible (to 10 min) and examined the
concentration-dependent uptake. [3H]-ribavirin was added to the bu®er with Na+ at 0.2
¹Ci/100 ¹L/oocyte and to the bu®er without Na+ at 1 ¹Ci/100 ¹L/oocyte.
In the bu®er with Na+ and without NBMPR (no inhibition), the uptake of ribavirin
showed a biphasic time course, as indicated by the Eadie-Hofstee plot (Fig. 2c). This
suggested that both types of transporter still worked as the phases observed at low and
high concentrations might have been due to hCNT3 and hENT1, respectively.
The uptake of ribavirin in the bu®er with Na+ and NBMPRÅ?(hENT inhibition
alone), and without Na+ and NBMPRÅ?(hCNT inhibition alone), followed Michaelis-
Menten-type kinetics. The kinetic parameters were Km=17.7 § 3.72 ¹M and Vmax=95.9
§ 3.85 pmol/oocyte/10 min with hENT inhibition (Fig. 2a), and Km=4.05 § 0.951 mM
and Vmax=892 § 70.2 pmol/oocyte/10 min with hCNT inhibition (Fig. 2b). These
values were comparable to those that were previously reported in the oocytes expressing
hCNT3 alone and hENT1 alone.Each type of transporter worked e®ectively in the oocytes
coexpressing hCNT3 and hENT1. This result shows that hCNT3 and hENT1 did not
interact in a direct way like a molecular interaction.
2.2.3 Ribavirin-induced current
We examined the transport activity of hCNT3 by monitoring the sodium current under
the inhibitory condition for hENT1. As shown in Fig. 3a, the ribavirin-induced current in
oocytes coexpressing hCNT3 and hENT1 showed voltage dependency and was una®ected
by adding NBMPR. Furthermore, the concentration dependency of the ribavirin-induced
current showed saturability (Fig. 3b). The Km and Imax values were 28.2 § 3.27 ¹M
and -157.0 § 7.12 nA for the uptake in the bu®er with Na+ and without NBMPRÅ?f
(no inhibition), and 36.5 § 5.03 ¹M and -161.9 § 9.50 nA for the uptake in the bu®er
with Na+ and NBMPRÅ?(hENT1 inhibition). No signi¯cant di®erence was observed in
these two conditions. This result con¯rmed that the transport through hCNT3 was not
inhibited by NBMPR and was similar to that without NBMPR.
2.2.4 E®ect of hENT1 expression level on uptake of ribavirin
The abovementioned results suggest that ribavirin transport activity of hCNT3 is altered
by neither addition of NBMPR nor co-expression of hENT1. We therefore assumed that
hENT1 transports ribavirin from inside to outside of the cells. It is opposite direction
against hCNT3 does. To examine this hypothesis, we changed the quantity of hENT1
cRNA injected into the oocytes from 0 ng to 50 ng in 12.5 ng increments, while the
quantity of hCNT3 cRNA was held constant at 50 ng (the total volume injected into the
oocytes was held constant at 50 nL). As shown in Fig. 4, according to the decrease in
the quantity of hENT1 cRNA, the uptake of ribavirin in the bu®er with Na+ and without
NBMPR (no inhibition) increased up to a level similar to that with Na+ and NBMPR
(hENT1 inhibition). The uptake seen with the hCNT3 inhibition increased as the quantity
of hENT1 cDNA increased, while the uptake remained constant in the presence of hENT
inhibition. These results suggest that hENT plays a key role in the process.
2.3 Summary of results and concluding remarks
The uptake of ribavirin by the oocytes was not merely the sum of the transport rates
through the two types of transporter, hCNT and hENT. It was strongly reduced by the
presence of hENT1. This suggests that an interaction mechanism might be involved in
the co-transport process between hCNT and hENT. We excluded the possibility that
NBMPR directly inhibited the transport activity of hCNT, by measuring the ribavirin-
induced sodium current. After examining the e®ect of the expression level of hENT1 on
the ribavirin uptake, we concluded that hENT alone played a critical role in the facilitated
transport that resulted from hENT inhibition.
This ¯nding is interesting from the point of view not only of drug delivery but also of
basic biology. One possible explanation is that ribavirin might be released through hENT,
although the concentration of ribavirin is still much lower inside the oocyte than outside
according to the estimated volume of the oocyte (0.9 ¹L). If the ribavirin concentration is
not homogeneous in the oocyte due to slow di®usion and/or other reasons, such as trapping
by large proteins, this phenomenon might occur. Nonetheless, quantitative analysis is
necessary to test the hypothesis and to discover other possibilities. We therefore focused
on the kinetics of this co-transport process, and considered a possible kinetic mechanism
by means of mathematical modeling of the transport.
3 Quantitative analysis of ribavirin transport
In this section, we describe a simpli¯ed version of the mathematical model [19]. Let us
begin with the assumption that the cell is a sphere and that ribavirin simply di®uses inside
and outside the cell. We therefore solve the di®usion equations using three-dimensional
polar coordinates. Transport across the membrane is mediated only by the transporters,
and other forms of transport such as leak are not included. The transporters mediate
both inward and outward °ows, the dynamics of which obey Michaelis-Menten kinetics.
Although the Km and VMAX generally di®er for the two directions of transport, here we
assume that they are the same for simplicity. We consider spatial variations only along
the radius, assuming that the spatial distribution of the ribavirin concentration always
shows spherical symmetry. The model equations are
@c(r; t)
@t
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(
Dinr2c; (cell inside, 0 · r < rm)
Doutr2c; (cell outside, rm < r · re); (1)
where c(r; t) is the ribavirin concentration, r is the coordinate of the radius (0 ·
r · re; r 6= rm), t is time, and Din and Dout are the respective di®usion constants inside
and outside the cell. The Laplacian operator in the polar coordinate is given by r2 =
@2=@r2+(2=r)(@=@r), where the derivatives along the angle in the polar coordinate is zero
because of the assumption of spherical symmetry in the spatial distribution of ribavirin.
Transport across the membrane is given as the boundary conditions as Jmembrane = J
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where Cin and Cout are the respective ribavirin concentrations directly inside and outside
the membrane, nin and nout are the respective sodium concentrations inside and outside
the membrane, and V and K are the maximum rate and Michaelis constant, respectively.
Exponent 2 in the sodium concentration comes from the fact that hCNT3 transports one
molecule of ribavirin and two molecules of sodium ion simultaneously.
Here we simplify the situations based on some physiological considerations. As the
amount of ribavirin in the extracellular medium is much larger than that which needs to
be transported across the membrane, we can neglect the small change in Cout. During the
physiological experiment the extracellular medium is stirred well, so the concentration
of ribavirin is homogenous in the extracellular space. It can therefore be assumed that
C = Cout in the extracellular medium. Based on similar considerations for sodium ions,
n = nout in the extracellular medium. For n in the intracellular space, we assume that n
is constant at nin because homeostasis is maintained quickly enough. Figure 5 shows a
schematic illustration of the mathematical modeling.
The details of the numerical calculation are described here. The cell is assumed to
be a sphere. The volume of the sphere is 0.9 ¹l, which is obtained from the experimental
measurement (rm = 0:6). The center of the sphere is de¯ned as the origin of the polar
coordinate. The extracellular space also follows the coordinate system. re is the boundary
of the extracellular space and re = 3mm. For the numerical simulation, the space is
discretized by a spherical shell with a thickness of 0.005 mm (= ¢). The spherical shell is
numbered from the origin outward (shell number j). Then, rm = 120£¢r; re = 600£¢r.
The space and time are discretized as rj = ¢r £ j mm and ti = ¢t £ i, and the model
equations are solved by the explicit di®erence scheme.
The parameters used are as follows, unless otherwise speci¯ed as follows: Dout =
5:4£ 102¹ m2 /sec (di®usion constant in extracellular space) , Din = 1:2£ 101¹ m2 /sec
(di®usion constant in intracellular space, and this was tested in the range from 1 £ 100
to 3 £ 103¹ m2=sec), nout = 96 £ 10¡3M (extracellular sodium ion), nin = 5 £ 10¡3M
(intracellular sodium ion) , V ENTMAX = V
in
ENT = V
out
ENT = 3:95 £ 10¡3 nmol/sec (equivalent
2370 pmol/10min, and V^ ENTMAX = 892 pmol/10min), K
ENT
m = K
in
ENT = K
out
ENT = 2:58£10¡4
M (0.26 mM, and K^ENTm = 4:1 mM), V
CNT
MAX = V
in
CNT = V
out
CNT = 1:65 £ 10¡4 nmol/sec
(equivalent to 99 pmol/10min, and V^ CNTMAX = 96 pmol/10min), K
CNT
m = K
in
CNT = K
out
CNT =
1:63 £ 10¡7 M3 (0.16 ¹M, and K^CNTm = 18¹ M). We will describe how these parameter
values are determined in the next section.
4 Numerical calculation and results
4.1 Parameter search for VMAX and Km in CNT and ENT
The experiment measured the relationship between the extracellular ribavirin concentra-
tion and the total uptake when one type of transporter was blocked. From the exper-
iments, we have calculated the V^MAX and K^m, which is of phenomenological e®ective
process for ribavirin uptake. Actually, however, this e®ective process consists of not only
uptake process but also release process by the transporter and intracellular di®usion pro-
cess. This means that the VMAX and Km for each process of uptake and release should be
determined so as to ¯t to the experimentally obtained V^MAX and K^m for the e®ective up-
take process. This is the important point to be emphasized because one may often confuse
V^MAX and K^m for the e®ective process with that for the elementary uptake process.
We therefore searched for the appropriate values of VMAX and Km for each process
of uptake and release by means of our mathematical model introduced in the previous
section, at the ¯xed value of Din = 12:0¹m
2/sec. Here we assume that VMAX and Km
for uptake process are the same as that of release process in order to reduce the degree
of freedom in parameter search, but there are still some degree of freedom. Figure 6
shows the error of ¯tting caused by changing VMAX and Km when one of transporters
was blocked. The error was de¯ned as the di®erence between cins of the experimentally
obtained and the theoretically simulated, which was summed up over a range of cout. We
determined V CNTMAX = 1:65£ 10¡4 nmol/sec, KCNTm = 1:63£ 10¡7M3, V ENTMAX = 3:95£ 10¡3
nmol/sec, KENTm = 2:58£ 10¡4 M.
For the sake of comparison to V^MAX and K^m, we show the values in the parenthesis
in the same unit. It is clear that there can be big di®erence. So it is very risky to confuse
them.
Using these values of VMAX and Km, we simulated the ribavirin uptake with and
without inhibition of each transporter. Although we assumed Din = 12:0¹m
2/sec, we
tested various values through the wide range of Din from 1 £ 100 to 3 £ 103¹ m2=sec in
order to evaluate reliability of the model, as shown in Fig. 7.
Ribavirin uptake increased by inhibition of hENT as it was observed in the experiment
all through the wide range of Din. Quantitatively speaking, the increase of uptake was
very similar in the model simulation and the experiment. This means that the model is
very robust.
So we don't have to be nervous about the Din value. The results described in the
next section are similar in the tested values of Din. We use 12:0¹m
2/sec as the best
value of ¯tting hereafter, although the value is, roughly speaking, 100 times smaller than
the typical value for molecule with the similar molecular weight (for instance, 3:2 £
102¹ m2=sec[20]).
Since nucleoside analogues like ribavirin are highly bioactive and potentially inter-
active with some protein, it is plausible that di®usion velocity of ribavirin is to be 10
times slower (equivalently 100 times smaller in di®usion constant) in space of protein-rich
protoplasm.
4.2 Uptake of ribavirin through transporters in the oocyte
Figure 8 shows the simulation results. There is a good agreement in all cases for the
CNT only, the ENT only, and both. As observed in the experiment, ribavirin uptake
is promoted by the inhibition of the ENT. The mathematical model essentially explains
the transport dynamics observed in the experiment over a wide range of Cout (0.12 ¹M
· Cout · 100¹M).
How does this increase occur when the ENT is blocked? Figure 9 sheds light on this
phenomenon. The ribavirin concentration increased directly inside the membrane when
the CNT transported the drug, as the di®usion of ribavirin in the cell was much slower
than the time scale of uptake by the CNT. Under these conditions, the ENT transported
the drug from inside the cell to outside. Therefore, ribavirin leaked through the ENT.
This explains why the uptake of ribavirin was promoted by the inhibition of the ENT.
This can be inferred from the mathematical model proposed here.
In the model proposed here, we assumed that the VMAXs and Kms for both directions
in the CNT were the same. We also made a similar assumption for the ENT. Under these
assumptions, we sought the appropriate range of VMAX ; Km values. Figure 8 shows an
example of the values. However, we predicted that the kinetic parameters would not
always be the same, because the transporter changed its molecular structure in di®erent
ways between the two directions of transport. As experimental evidence of the kinetic
di®erence between the two directions of transport is limited, model prediction can be
generally useful.
4.3 Inhibition of uptake by stirring the extracellular medium
In the simulation described above, we assumed that c(r; t) = cout in the extracellular
space. However, when the extracellular medium was not stirred and ribavirin di®used
through it, the model simulation showed that the uptake of ribavirin was 20% less than
that in the case with stirring, as shown in Fig. 10a. Figure 10b indicates the mechanism
of inhibition. The ribavirin concentration was low directly outside the membrane because
the uptake by the CNT was much faster that the time scale of di®usion in the extracellular
medium. The uptake by the CNT then slowed down, as predicted by the model.
4.4 E®ects of CNT/ENT ratio on the ribavirin uptake
The CNT/ENT ratio is reported to vary in di®erent organs. According to the model
analysis described here, ribavirin uptake is promoted more strongly as the ratio of the
ENT is reduced relative to the CNT. In the simulation, a 20 | 30% di®erence in the
ratio leads to a large di®erence in the uptake, as shown in Fig. 11. This implies that
organ-selective drug delivery to ENT-poor organs can be achieved by controlling the drug
concentration in the circulating blood.
5 Conclusion
We found that hENT1 reduced the ribavirin uptake via hCNT3 transport through a kinetic
interaction of hENT1 and hCNT3 in Xenopus oocytes in which hENT1 and hCNT3 were
simultaneously expressed. Quantitative analysis of the kinetics of ribavirin uptake was
performed. In the predicted mechanism, the ribavirin pumped inward by hCNT3 was
highly concentrated directly inside the membrane due to slow di®usion, and was released
outward through hENT1. Based on this mechanism, we proposed that organ-selective
drug delivery to ENT-poor organs was feasible by controlling the drug concentration in
the circulating blood.
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Figure Captions
Figure 1:
E®ects of Na+ and NBMPR on ribavirin uptake in Xenopus oocytes coexpressing hCNT3
and hENT1. The oocytes were incubated at room temperature with 123 nM ribavirin (0.1
¹Ci/100 ¹L/oocyte) in bu®er consisting of 96 mM NaCl with or without 10 ¹M NBMPR,
and NMDG Cl with or without 10 ¹M NBMPR. Panel (a) shows the uptake for 1 min
(?P < 0.05, ??P < 0.01, ???P < 0.001, signi¯cantly di®erent) and panel (b) shows the time
course of the uptake. Each value is the mean § SE of six measurements.
Figure 2:
Concentration dependency of ribavirin uptake by Xenopus oocytes coexpressing hCNT3
and hENT1. (a) In the bu®er with Na+ and NBMPR (hENT1 inhibition alone). (b) In
the bu®er without Na+ and NBMPR (hCNT3 inhibition alone). (c) In the bu®er with
Na+ and without NBMPR (no inhibition). Oocytes were incubated for 10 min at room
temperature in the bu®er consisting of 96 mM NaCl and NMDG Cl with or without
NBMPR, and the uptake was determined based on the in°ux into the RNA-injected
oocytes minus the in°ux into the H2O-injected oocytes over a ribavirin concentration
range of 1¹M-500 ¹M (a) or 1 ¹M-20 mM (b, c). Each value is the mean § SE of six
measurements. Inset, Eadie-Hofstee plot.
Figure 3:
Ribavirin-induced currents in Xenopus oocytes coexpressing hCNT3 and hENT1. The
oocytes were perfused with ribavirin in the bu®er with (open circles) or without (closed
circles) 10 ¹M NBMPR, and the ribavirin-induced currents were monitored using the
TEVC technique. (a) Dependence of ribavirin-induced currents on ribavirin concentration
(2.5-100 ¹M) and membrane potential (+50 to -150 mV). (b) Concentration dependence
of ribavirin-induced currents (clamped at -50 mV). Each value is the mean of ¯ve mea-
surements.
Figure 4:
E®ect of hENT1 expression level on ribavirin uptake by Xenopus oocytes coexpressing
hCNT3 and hENT1. The oocytes were injected with 50 ng hCNT3 cRNA and 0, 12.5,
25, 37.5, or 50 ng hENT1 cRNA. The concentration of ribavirin was 123 nM (labeled
compound alone, 0.1 ¹Ci/100 ¹L/oocyte), and the oocytes were incubated for 1 min at
room temperature in bu®er containing 96 mM NaCl and NMDG Cl with or without 10 ¹M
NBMPR. To reduce the in°uence of the metabolism of ribavirin as much as possible, we
shortened the incubation time by 1 min. Each value is the mean§ SE of six measurements.
Figure 5:
Schematic illustration of model setup. Di®usion of ribavirin concentration c(r; t) was
considered along the r axis of the three-dimensional polar coordinate. At the cell mem-
brane r = rm, transport by the transporters was considered. The boundary condition at
r = 0; re was of the no-°ux type. In some simulations, c was a constant (cout).
Figure 6:
Search for the kinetic parameters for the CNT (a) and the ENT (b). A darker shade
indicates a smaller error in ¯tting the experimental data for the relationship between
the extracellular concentration of ribavirin and the total ribavirin uptake when one of
the transporters was blocked. The de¯nition of the error is given in the main text of
subsection 4.1.
Figure 7:
E®ects of variations of Din value on ribavirin uptake with and without inhibitions of
each of transporter. As observed in the experiments, ribavirin uptake increased by ENT
inhibition (see the di®erence between the open and the closed circles). This increase
of ribavirin uptake was observed all through the wide range of Din from 1 £ 100 to
3£ 103¹ m2=sec in order to evaluate reliability of the model. The white arrow indicates
a typical value 3:2 £ 102¹ m2=sec, obtained from the literature[20], and the black one
indicates the value 12¹ m2=sec, used in the simulation hereafter.
Figure 8:
Comparison of simulation results (black columns) with biological experiments (white
columns) for ribavirin uptake. The total amount of ribavirin transported into the cell was
measured 10 min after the addition of ribavirin to the extracellular medium. cout =0.12¹M
(a), 1.0¹M (b), 10¹M (c), and 100¹M (d). ENT & CNT, coexistence of ENT and CNT;
ENT, ENT only; CNT, CNT only. The simulation reproduced the ¯nding that the uptake
was strongly inhibited by coexisting CNT and ENT in comparison to the CNT alone. All
of parameter values are shown in the last paragraph of section 3.
Figure 9:
Kinetic mechanism for the promotion of ribavirin uptake by inhibition of ENT. Spatial
distribution of ribavirin concentration 10 min after the addition of ribavirin to the ex-
tracellular medium (cout = 10¹M). (a) ENT only. (b) CNT only. Ribavirin was highly
concentrated directly inside the membrane. (c) ENT and CNT. The ribavirin concen-
tration was lower than that with the CNT only, because ribavirin leaked according to
the concentration gradient across the membrane. rm indicates the position of the cell
membrane.
Figure 10:
E®ects of stirring the extracellular medium on ribavirin uptake. (a) Total amount of rib-
avirin uptake 10 min after the addition of ribavirin to the extracellular medium (cout =
10¹M). The white columns indicate the experiment, and the black and dark columns
indicate the respective simulation results with and without stirring. The update of rib-
avirin was reduced by about 20% by not stirring. (b) Spatial distribution of ribavirin. The
ribavirin concentration was low directly outside the cell membrane because the di®usion
of ribavirin was slow. The transport by the CNT was then slowed down.
Figure 11:
Dependency of uptake on the ratio of transporters. The ratio in the abscissa axis was
given by CNT/(CNT+ENT). The uptake in the ordinate was calculated 10 min after the
addition of ribavirin, and expressed the total amount normalized to that of ENT=0. The
uptake was reduced as the ratio of the ENT became larger.
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